Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rafael Bejar
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Correction To: The Prognostic Value of Serum Erythropoietin in Patients With Lower-Risk Myelodysplastic Syndromes: A Review of the Literature and Expert Opinion
Annals of Hematology
Medicine
Hematology
Prognostic Significance of U2AF1 Mutations in Myelodysplastic Syndromes: A Meta-Analysis
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Improving Prognostic Tools for Patients With Myelodysplastic Syndromes
Mayo Clinic Proceedings
Medicine
Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Long-Term Outcome of Immunosuppressive Therapy for Japanese Patients With Lower-Risk Myelodysplastic Syndromes
International Journal of Hematology
Hematology
Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Cytogenetic Prognostic Factors in Myelodysplastic Syndromes
Hematology & blood transfusion: interdepartamental collection
The Impact of Sex on Disease Phenotype and Prognostic Thresholds of Anemia in Myelodysplastic Syndromes
American Journal of Hematology
Hematology
There’s Risk, and Then There’s RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
